Fundz

AstraNu closes $3.5 million seed round led by Celesta Capital to commercialize its chip-scale optical imaging engine.

PRIVATENov 17, 2026

Amount Raised

$3.5 Million

Round Type

Seed

New JerseyManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage Recognition

Investors

New Jersey Innovation Evergreen FundCelesta Capital

Description

AstraNu has successfully closed a $3.5 million seed funding round with Celesta Capital leading the investment, alongside co-investment from NJIEF. The funding will be used to build the company's photonics development team and prepare for volume manufacturing. This capital will enable AstraNu to validate the performance of its innovative imaging engine. The company aims to deliver higher imaging performance while keeping costs competitive for the medical device industry.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as AstraNu that raised within 45 days of this round, from Fundz verified event records.

  • Nami Surgical raised $4.5M (Series A) on October 13, 2026.
  • Soombit AI raised $9M (Series A) on November 17, 2026.
  • TestDynamics raised $9M (Series A) on November 16, 2026.
  • Remedy Robotics raised $62M (Series B) on November 16, 2026.
  • Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
  • Total Joint Orthopedics raised $11M (Debt Financing) on October 21, 2026.

Who to call at AstraNu, and when

A new round usually means AstraNu is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AstraNu raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AstraNu, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AstraNu. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AstraNu

Location

New Jersey, United States

About

AstraNu develops a chip-scale optical coherence tomography imaging engine that gives medical device manufacturers swept-source performance at a fraction of the size and cost of conventional systems. The company spun out of Nokia Bell Labs in 2025 and is focused on enabling high-performance imaging in new products and clinical applications. Its initial market focus is ophthalmology, while also exploring applications in ENT, urology, and oncology. AstraNu aims to validate its technology and partner with established companies in the imaging and optics field.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AstraNu raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AstraNu's next move

See what Strategic adds

AstraNu raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.